These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4946009)

  • 1. Comparison of 1 -testololactone (NSC-23759) and an estrogen-progestin combination (NSC-77622) in the treatment of metastatic breast cancer.
    Talley RW; O'Bryan RM; Burrows JH; San Diego EL
    Cancer Chemother Rep; 1970 Aug; 54(4):249-53. PubMed ID: 4946009
    [No Abstract]   [Full Text] [Related]  

  • 2. Teslac.
    Med Lett Drugs Ther; 1970 May; 12(11):45-6. PubMed ID: 4935986
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hormone treatment of breast cancer in the advanced phase].
    Demol R
    Brux Med; 1968 Oct; 48(10):665-9. PubMed ID: 5757971
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical trial of delta-1-testololactone (NSC 23759), medroxy progesterone acetate (NSC 26386) and oxylone acetate (NSC 47438) in advanced female mammary cancer. A report of the cooperative breast cancer group.
    Goldenberg IS
    Cancer; 1969 Jan; 23(1):109-12. PubMed ID: 4884063
    [No Abstract]   [Full Text] [Related]  

  • 5. [A method of testing the antitumor effectiveness of drugs on induced rat mammary gland cancer].
    Beskrovnyĭ AM
    Vopr Onkol; 1970; 16(8):62-6. PubMed ID: 5501884
    [No Abstract]   [Full Text] [Related]  

  • 6. Towards a new chemotherapy for endometriosis: an experimentalist's perspective.
    Matsumura KN
    Exp Med Surg; 1970; 28(1):18-23. PubMed ID: 5508496
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of testosterone decanoate, drostanolone and testololactone in disseminated breast cancer--a randomized clinical study.
    Rieche K; Wolff G
    Arch Geschwulstforsch; 1975; 45(5):485-8. PubMed ID: 1243528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined high-dose delta1-testololactone with low-dose 5-fluorouracil in the treatment of metastatic breast cancer.
    Halden A; Horn Y; Walter RM; Gordan GS; Shonfeld EM
    Oncology; 1973; 27(6):493-501. PubMed ID: 4742676
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dosage delta-1-testololactone therapy of disseminated carcinoma of the breast.
    Cantino TJ; Gordan GS
    Cancer; 1967 Mar; 20(3):458-61. PubMed ID: 6021501
    [No Abstract]   [Full Text] [Related]  

  • 10. Observations on the hormone sensitivity of 7,12-dimethylbenz(alpha)anthracene-induced mammary tumors in the Sprague-Dawley rat.
    Griswold DP; Green CH
    Cancer Res; 1970 Mar; 30(3):819-26. PubMed ID: 5463906
    [No Abstract]   [Full Text] [Related]  

  • 11. Testolactone aqueous suspension (Teslac).
    Clin Pharmacol Ther; 1970; 11(2):302-6. PubMed ID: 5416857
    [No Abstract]   [Full Text] [Related]  

  • 12. [HORMONE TREATMENT OF BREAST CANCER IN THE ADVANCED PHASE. COMPARISON BETWEEN TESTOSTERONE PROPIONATE AND THE TESTOSTERONE-DELTA-1-TESTOLOLACTONE COMBINATION].
    ROYER P; DELAITRE R; MATHIEU H; GABILAN JC; RAYNAUD C; PASQUALINI JR; DEBRIS P; GERBEAUX S; HABIB R
    Rev Fr Etud Clin Biol; 1964 Jan; 9():88-90. PubMed ID: 14129164
    [No Abstract]   [Full Text] [Related]  

  • 13. [THE HORMONAL TREATMENT OF ADVANCED BREAST CANCER. STUDY METHODS: COMPARISON OF DELTA-1-TESTOLOLACTONE WITH TESTOSTERONE PROPIONATE].
    VANRYMENANT M; COUNE A; TAGNON HJ; SIMON S
    Acta Clin Belg; 1963; 18():469-79. PubMed ID: 14110611
    [No Abstract]   [Full Text] [Related]  

  • 14. delta 1-testololactone: clinical trials'.
    Segaloff A
    Cancer Res; 1982 Aug; 42(8 Suppl):3387s-3388s. PubMed ID: 7044522
    [No Abstract]   [Full Text] [Related]  

  • 15. Calusterone (NSC-88536): a poor substitute for fluoxy-mesterone (NSC-12165) in the treatment of advanced breast cancer.
    Falkson G; van Dyk JJ; van Eden EB; van der Merwe AM; FALKSON HC
    Cancer Chemother Rep; 1974; 58(6):939-41. PubMed ID: 4615788
    [No Abstract]   [Full Text] [Related]  

  • 16. Estrogen synthesis in human breast tumor and its inhibition by testololactone and bromoandrostenedione.
    Dao TL
    Cancer Res; 1982 Aug; 42(8 Suppl):3338s-3341s. PubMed ID: 7083197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Behavior of serum lactic dehydrogenase (LDH) in disseminated breast cancer treated with delta-1-testololactone].
    MARGOTTINI M; JACOBELLI G; CAU M
    Gazz Int Med Chir; 1962 Dec; 66():2890-9. PubMed ID: 13933033
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pure antiestrogen for treatment of advanced breast cancers].
    Nomura Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():334-9. PubMed ID: 11026015
    [No Abstract]   [Full Text] [Related]  

  • 19. A dose response evaluation of delta-1-testololactone in advanced breast cancer.
    Volk H; Deupree RH; Goldenberg IS; Wilde RC; Carabasi RA; Escher GC
    Cancer; 1974 Jan; 33(1):9-13. PubMed ID: 4129562
    [No Abstract]   [Full Text] [Related]  

  • 20. MICROBIAL FORMATION AND HYDROLYSIS OF TESTOLOLACTONE.
    HOLMLUND CE; BLANK RH; SAX KJ; EVANS RH
    Arch Biochem Biophys; 1963 Oct; 103():105-10. PubMed ID: 14065962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.